astria therapeutics glp-1 receptor agonist weight management diabetes treatments Advances in agonists delivery systems for obesity and Evolution of GLP‐1 Receptor Agonists

However, major expansion of the GLP-1 receptor agonist market in the US is fueled by heavy investments in research and development of new therapies by many pharmaceutical industries

Bastick, A

Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights

Weight loss drugs are prescribed to individuals with obesity or individuals who are overweight and managing a weight-related health condition

Orlistat-associated adverse effects and drug interactions